ReposiTrak, Inc. Form 4 Filings

ReposiTrak, Inc.’s Form 4 shows an open-market sale of 7,500 shares of Common Stock at a weighted average price of $8.0596 per share. The sale was made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan to help meet charitable commitments.

After this transaction, that LLC holds 70,000 ReposiTrak shares indirectly for Randall K. Fields. The filing also reports Fields directly owning 3,483,955 Common shares, along with additional indirect holdings, including 615,260 Common shares via Riverview Financial Corp., 333,643 via Fields Management, Inc., and related Series B Preferred Stock positions.

ReposiTrak, Inc. director and CEO Randall K. Fields reported pre-planned insider sales executed by a charitable entity associated with him. RK Fields Charitable 2022, LLC sold a total of 7,500 shares of ReposiTrak common stock in open-market transactions on March 16–17, 2026 at weighted average prices slightly above $8 per share.

The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the related charitable trust to help meet charitable commitments. After these sales, that LLC held 77,500 shares. The Form 4 also shows Fields continues to hold 3,483,955 ReposiTrak common shares directly, plus additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.

ReposiTrak, Inc. director and CEO Randall K. Fields reported an indirect open-market sale of 4,000 shares of Common Stock at a weighted average price of $8.0599 per share. The shares were sold by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments, with individual trade prices ranging from $7.91 to $8.17. Following the sale, that LLC holds 85,000 shares, while Fields also reports 3,483,955 shares held directly and additional indirect positions through affiliated entities and his spouse.

ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported that RK Fields Charitable 2022, LLC, an entity he manages as trustee of a charitable remainder unitrust, sold 3,500 shares of common stock on March 9, 2026 at a weighted average price of $8.5612 per share.

The sale was executed automatically under a pre-established Rule 10b5-1 trading plan designed to help meet charitable commitments. After this transaction, that LLC held 89,000 shares, while Fields also reported 3,483,955 shares held directly and additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.

ReposiTrak, Inc. reported that an entity associated with Chief Executive Officer Randall K. Fields sold a total of 7,500 shares of common stock in open‑market transactions. The sales, made by RK Fields Charitable 2022, LLC under a Rule 10b5‑1 trading plan, occurred on March 2, 3, and 4, 2026 at weighted average prices of $8.75, $8.55, and $8.6182 per share, respectively.

The trading plan was adopted by Mr. Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments. After these sales, RK Fields Charitable 2022, LLC held 92,500 shares of common stock. The filing also lists additional direct and indirect holdings, including 3,483,955 common shares held directly as of March 2, 2026, along with stakes held through Riverview Financial Corp., Fields Management, Inc., and by his spouse, plus holdings of Series B Preferred Stock through Riverview Financial Corp. and his spouse.

ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported indirect sales of company common stock through an affiliated charitable entity. RK Fields Charitable 2022, LLC sold 7,500 shares in open-market transactions, consisting of 5,300 shares on February 25, 2026 at a weighted average price of $8.3369 per share and 2,200 shares on February 24, 2026 at a weighted average price of $8.5026 per share. According to the disclosure, these sales occurred automatically under a pre-established Rule 10b5‑1 trading plan adopted by Fields in his capacity as trustee of a charitable remainder unitrust to help meet charitable commitments, and RK Fields Charitable 2022, LLC held 100,000 shares of ReposiTrak common stock after the transactions.

ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported indirect open-market sales of the company’s common stock by an affiliated charitable entity. On February 19, 2026, RK Fields Charitable 2022, LLC sold 4,500 shares at a weighted average price of $9.0652 per share. On February 20, 2026, the same entity sold 3,000 shares at a weighted average price of $8.8238 per share under a Rule 10b5-1 trading plan adopted to help meet charitable commitments. Following these transactions, this LLC held 107,500 shares, while Fields also reported 3,483,955 shares of common stock held directly and additional indirect holdings through other related entities and his spouse, as well as indirect holdings of Series B preferred stock.

ReposiTrak, Inc. insider trading disclosure: Randall K. Fields, the company’s Chief Executive Officer, director, and 10% owner, reported automatic sales of ReposiTrak common stock executed by RK Fields Charitable 2022, LLC under a prearranged Rule 10b5-1 trading plan.

The charitable LLC sold 3,000 shares on February 2, 2026 at a weighted average price of $10.4754 per share and 4,500 shares on February 4, 2026 at a weighted average price of $10.6195 per share. Following these transactions, the LLC held 119,500 and then 115,000 shares, respectively, while Fields also reported substantial additional direct and indirect beneficial ownership in common and Series B preferred stock.

ReposiTrak, Inc. insider activity shows stock sales by an entity affiliated with CEO, director and 10% owner Randall K. Fields. RK Fields Charitable 2022, LLC sold 2,500 common shares on February 2, 2026 at a weighted average price of $11.0061 and 5,000 shares on February 4, 2026 at a weighted average price of $10.4697. These automatic sales were made under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After these transactions, the LLC still held 122,500 shares, while Fields also reported direct ownership of 3,483,955 common shares and additional indirect holdings through Riverview Financial Corp., his spouse, Fields Management, Inc., and Series B preferred stock interests.

ReposiTrak, Inc.’s chief executive officer, director, and 10% owner Randall K. Fields reported an automatic sale of common stock by an affiliated charitable entity. On January 26, 2026, RK Fields Charitable 2022, LLC sold 7,500 shares of ReposiTrak common stock at a weighted average price of $11.0742 per share under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After this sale, RK Fields Charitable 2022, LLC held 130,000 common shares. Fields also reported 3,483,955 common shares held directly, and indirect common holdings including 615,260 shares through Riverview Financial Corp., 30,667 shares by his spouse, and 333,643 shares through Fields Management, Inc., plus Series B Preferred Stock held indirectly via Riverview Financial Corp. and his spouse.

ReposiTrak, Inc. insider holdings data show that RK Fields Charitable 2022, LLC, an entity associated with CEO, director and 10% owner Randall K. Fields, sold common stock in two Rule 10b5-1 plan transactions. The LLC sold 2,500 shares of common stock on January 20, 2026 at a weighted average price of $10.9697, and 5,000 shares on January 21, 2026 at a weighted average price of $10.9106. These sales were made under a pre-established Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments, and the LLC now holds 137,500 common shares. Fields also reports additional ownership of ReposiTrak securities, including 3,483,955 common shares held directly, further common shares held through entities such as Riverview Financial Corp., his spouse and Fields Management, Inc., and Series B Preferred Stock held indirectly through Riverview Financial Corp. and his spouse.

ReposiTrak, Inc. insider filing shows planned charitable-related stock sales by entities associated with CEO and 10% owner Randall K. Fields. A Rule 10b5-1 trading plan for RK Fields Charitable 2022, LLC executed sales of ReposiTrak common stock on three days: 1,000 shares on 01/14/2026 at a weighted average price of $11.094, 3,600 shares on 01/15/2026 at $11.0786, and 2,900 shares on 01/16/2026 at $10.8452. The trading plan was established to help the reporting person meet charitable commitments.

After these transactions, RK Fields Charitable 2022, LLC held 145,000 shares of common stock. As of 01/14/2026, Randall K. Fields also beneficially owned 3,483,955 common shares directly, plus additional common and Series B preferred stock indirectly through Riverview Financial Corp., his spouse, Fields Management, Inc., and other related holdings.

ReposiTrak director Robert W. Allen reported selling 8,280 shares of Series B Preferred Stock at $10.70 per share on 12/31/2025. After this transaction, he directly held 22,411 shares of Series B Preferred Stock. He also reported direct ownership of 199,147 shares of common stock, plus indirect holdings of 587,476 common shares through a trust and 2,775 common shares held by his spouse.

ReposiTrak, Inc. insider activity shows several transactions by entities associated with Chief Executive Officer Randall K. Fields, who is also a director and 10% owner. RK Fields Charitable 2022, LLC sold 5,000 shares of common stock on January 5, 2026 at a weighted average price of $12.2686 per share and 2,500 shares on January 6, 2026 at a weighted average price of $11.7238 per share under a pre-arranged Rule 10b5-1 trading plan set up to help meet charitable commitments. After these sales, this LLC held 155,000 and then 152,500 common shares. On December 31, 2025, Riverview Financial Corp and the reporting person’s spouse disposed of 60,411 and 1,402 shares of Series B preferred stock at $10.70 per share, leaving 169,797 and 3,704 preferred shares, respectively. As of that date, Fields also held 3,483,955 common shares directly, plus additional indirect common holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.

ReposiTrak, Inc. insider Randall K. Fields, who serves as Chief Executive Officer, director, and a 10% owner, reported an automatic sale of company stock. On 12/31/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 7,500 shares of common stock at a weighted average price of $12.3449 per share under a pre-established Rule 10b5-1 trading plan. The filing states that this trading plan was set up to help Mr. Fields meet certain charitable commitments. After the reported transaction, Mr. Fields continues to report substantial holdings in ReposiTrak common and preferred stock through multiple entities and family holdings.

ReposiTrak, Inc. director reports stock grant and sales

A director of ReposiTrak, Inc. (TRAK) reported several transactions in the company’s common stock. On November 5, 2025, he acquired 1,265 shares, issued in lieu of cash compensation for his board service for the quarter ended September 30, 2025. On December 22, 2025, he sold 1,641 shares at a weighted average price of $13.1981, and on December 23, 2025 he sold an additional 18,906 shares at a weighted average price of $13.164. After these transactions, he beneficially owned 561,869 shares of ReposiTrak common stock, held directly.

ReposiTrak, Inc. director Robert Allen reported receiving 1,265 shares of common stock on 11/05/2025. These shares were issued instead of cash payments for his service on the company’s Board of Directors for the quarter ended September 30, 2025.

After this transaction, he beneficially owned 199,147 shares of common stock directly, 587,476 shares indirectly through a trust, 2,775 shares indirectly through his spouse, and 39,704 shares of Series B preferred stock directly.

ReposiTrak, Inc. chief executive officer, director and 10% owner Randall K. Fields reported small insider stock sales executed under a Rule 10b5-1 trading plan. On 12/22/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 3,000 shares of common stock at a weighted average price of $13.3687 per share. On 12/23/2025, the same entity sold an additional 4,500 shares at a weighted average price of $13.2618 per share. The filing explains that the trading plan was adopted by Fields, in his capacity as trustee of a charitable remainder unitrust, to help meet his charitable commitments. After these sales, Fields continues to beneficially own 3,483,955 shares of common stock directly, plus additional indirect holdings through family and affiliated entities.

ReposiTrak, Inc. reported that CEO, director and 10% owner Randall K. Fields sold 7,500 shares of common stock on 12/16/2025 at a weighted average price of $13.2977, coded as an "S" sale transaction.

The sale occurred automatically under a Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC, and was established to help meet some of his charitable commitments.

After this transaction, Fields beneficially owned 3,483,955 shares of common stock directly, 175,000 shares of common stock indirectly through RK Fields Charitable 2022, LLC, 615,260 common and 229,262 Series B preferred shares through Riverview Financial Corp, 30,667 common and 5,320 Series B preferred shares through his spouse, and 333,643 common shares through Fields Management, Inc.

ReposiTrak, Inc. chairman and chief executive officer Randall K. Fields, who is also a director and 10% owner, reported a series of automatic sales of ReposiTrak common stock made by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan.

The LLC sold 4,453 shares on 12/03/2025 at a weighted average price of $13.4023, 3,000 shares on 12/08/2025 at $13.7212, 2,500 shares on 12/09/2025 at $13.6363, and 2,000 shares on 12/10/2025 at $13.6991, all coded as open-market sales. The prices reflect multiple trades within disclosed price ranges on each day.

Following these transactions, RK Fields Charitable 2022, LLC held 182,500 shares of ReposiTrak common stock. Fields also reported additional holdings, including 3,483,955 shares of common stock held directly and various indirect positions through entities such as Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as related preferred stock holdings.

ReposiTrak, Inc.’s chief executive officer, director and 10% owner Randall K. Fields reported small open-market sales of the company’s common stock. On 12/01/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 2,000 shares at a weighted average price of $13.3836. On 12/02/2025, the same entity sold 1,047 shares at a weighted average price of $13.0045. Both transactions occurred under a pre-arranged Rule 10b5-1 trading plan designed to help Fields meet charitable commitments through the 2022 RK Fields Charitable Remainder Unitrust. After these sales, he reports indirect ownership of 194,453 shares through RK Fields Charitable 2022, LLC, along with additional direct and indirect holdings through other entities and his spouse.

ReposiTrak, Inc. (TRAK) CEO and 10% owner Randall K. Fields reported multiple stock movements involving company shares. On 11/24/2025, 200,000 shares of common stock were transferred out of his direct ownership and 200,000 shares were received by RK Fields Charitable 2022, LLC as a gift at a reported price of $0. The same day, that charitable entity sold 1,000 shares at a weighted average price of $13.1169, followed by an additional sale of 6,500 shares on 11/25/2025 at a weighted average price of $13.1791.

The sales were executed automatically under a Rule 10b5-1 trading plan established to help meet charitable commitments. Following these transactions, Fields reported continued indirect holdings through several entities, including RK Fields Charitable 2022, LLC, Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as direct ownership of ReposiTrak common stock.

ReposiTrak, Inc. (TRAK) insider Randall K. Fields, who is a director, 10% owner and chief executive officer, reported automatic sales of common stock by an affiliated charitable entity. On 11/17/2025, 11/19/2025, and 11/20/2025, RK Fields Charitable 2022, LLC sold 1,000, 4,500 and 2,000 shares of ReposiTrak common stock, respectively, at weighted average prices of $14.807, $14.0109 and $13.4659. The filing states these transactions were executed under a pre-established Rule 10b5-1 trading plan designed to help Fields meet charitable commitments. Following these trades, Fields continues to report significant holdings, including 3,683,955 shares of common stock held directly, plus additional common and Series B preferred shares held indirectly through entities and a spouse.

ReposiTrak, Inc. (TRAK): CEO, director and 10% owner Randall K. Fields reported two open‑market sales under a Rule 10b5‑1 plan. On 11/10/2025, the RK Fields Charitable 2022, LLC sold 1,600 shares at a weighted average price of $15.0326. On 11/11/2025, it sold 5,900 shares at a weighted average price of $15.0248.

Following these transactions, the charitable LLC held 12,500 shares indirectly. Additional reported holdings include 3,683,955 shares directly; 615,260 shares indirectly by Riverview Financial Corp.; 333,643 shares indirectly by Fields Management, Inc.; 30,667 shares indirectly by spouse; and Series B Preferred holdings of 229,262 shares indirectly by Riverview Financial Corp. and 5,320 shares indirectly by spouse. The filing notes the plan was established to meet charitable commitments.

ReposiTrak (TRAK) disclosed an insider transaction on a Form 4. CEO, Director and 10% owner Randall K. Fields reported a sale of 7,500 shares of common stock on 11/03/2025 at a weighted average price of $15.0126, executed under a Rule 10b5-1 trading plan to meet charitable commitments. The filing notes the shares were sold in multiple trades between $15.00 and $15.10. Following the transaction, reported holdings include 3,683,955 shares direct and various indirect positions, including 20,000 by RK Fields Charitable 2022, LLC.

ReposiTrak (TRAK) disclosed insider transactions by Randall K. Fields, its Chief Executive Officer, director, and 10% owner. Acting through RK Fields Charitable 2022, LLC under a Rule 10b5-1 trading plan, he sold a total of 7,500 shares across three days: 3,800 shares on 10/28/2025 at a weighted average price of $15.2786, 1,000 shares on 10/29/2025 at $15.1774, and 2,700 shares on 10/30/2025 at $14.9978. The plan was established to meet charitable commitments.

Following the reported transactions, beneficial holdings included 27,500 shares indirectly by RK Fields Charitable 2022, LLC and 3,683,955 shares held directly, with additional indirect holdings reported through Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as Series B Preferred Stock holdings.

ReposiTrak, Inc. (TRAK) CEO, Director, and 10% owner Randall K. Fields reported a sale of common stock on 10/20/2025. The filing shows a disposition of 7,500 shares coded “S,” executed under a Rule 10b5-1 trading plan established to meet charitable commitments.

The weighted average sale price was $15.467, with individual trades ranging from $14.80 to $15.21. Following the reported transaction, the filing lists 35,000 shares indirectly held by RK Fields Charitable 2022, LLC.

Additional beneficial holdings disclosed include 3,683,955 shares (direct), 615,260 shares indirectly by Riverview Financial Corp., 30,667 shares indirectly by spouse, and 333,643 shares indirectly by Fields Management, Inc. The filing also lists Series B Preferred Stock positions: 289,673 shares indirectly by Riverview Financial Corp. and 6,721 shares indirectly by spouse.

ReposiTrak (TRAK) disclosed that CEO, director and 10% owner Randall K. Fields sold a total of 7,500 shares of common stock on October 14–15, 2025 under a Rule 10b5-1 trading plan executed through RK Fields Charitable 2022, LLC, established to help meet charitable commitments.

Transactions included: 1,500 shares at a weighted average price of $14.7377 on 10/14, 1,640 shares at $14.4227 on 10/14, and 4,360 shares at $14.4227 on 10/15. Following these sales, the filing shows 42,500 shares held indirectly by the charitable LLC and 3,683,955 shares held directly, alongside additional indirect holdings through affiliated entities.

Randall K. Fields, who serves as Chief Executive Officer, Director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a sale of 7,500 shares of common stock on 10/07/2025 at a weighted average price of $14.9711 per share under a Rule 10b5-1 trading plan. The filing shows substantial remaining holdings: 3,683,955 shares held directly, 615,260 shares indirectly via Riverview Financial Corp., 333,643 via Fields Management, Inc., and other indirect holdings including 50,000 shares held by RK Fields Charitable 2022, LLC.

The sale was executed automatically to satisfy charitable commitments and occurred across multiple transactions with prices ranging from $14.16 to $15.21. No derivative securities were reported as changed in this filing.

Randall K. Fields, CEO, director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple sales of Common Stock under an existing Rule 10b5-1 trading plan established to meet charitable commitments. The Form 4 shows five reported dispositions executed on 09/29/2025, 09/30/2025 and 10/01/2025 totaling 7,500 shares sold at weighted-average prices ranging from approximately $14.91 to $16.97 per share. The sales were made indirectly by RK Fields Charitable 2022, LLC pursuant to the trustee role in a charitable remainder unitrust. The filing lists significant remaining holdings held directly and indirectly, including large direct and indirect positions in common stock and Series B preferred stock across related entities and spouse holdings.

Randall K. Fields, CEO, Director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple dispositions of company stock on 09/22/2025 and 09/23/2025. The report shows sales of 3,000 shares on 09/22/2025 at a weighted average price of $17.5775 and 4,000 shares on 09/23/2025 at a weighted average price of $17.3856, executed pursuant to a Rule 10b5-1 trading plan established by the reporting person as trustee of a charitable unitrust.

The Form 4 discloses significant other holdings and dispositions: a reported disposition of 3,683,955 shares of common stock, direct ownership of 615,260 shares indirectly, and various indirect holdings through Riverview Financial Corp., spouse, Fields Management, Inc., and a charitable LLC. Footnotes state the sales occurred in multiple transactions and provide price ranges for each weighted average.